Ownership Submission
FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Smith David Ross
2. Date of Event Requiring Statement (Month/Day/Year)
08/12/2015
3. Issuer Name and Ticker or Trading Symbol
CHARLES RIVER LABORATORIES INTERNATIONAL INC [CRL]
(Last)
(First)
(Middle)
251 BALLARDVALE STREET
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Corporate Executive VP & CFO
5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

WILMINGTON, MA 01887
6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock (1) 4,511
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(Month/Day/Year)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (Right to Buy) 05/01/2015(2) 05/01/2021 Common Stock 20,597 $ 51.45 D  
Stock Options (Right to Buy) 02/27/2016(3) 02/27/2020 Common Stock 8,631 $ 76.67 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Smith David Ross
251 BALLARDVALE STREET
WILMINGTON, MA 01887
      Corporate Executive VP & CFO  

Signatures

/s/ David R. Smith 08/12/2015
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Consists of: (a) 365 shares of common stock; (b) 2,190 shares of restricted stock which vest as follows: 730 shares on 5/01/2016, 730 shares on 5/01/2017 and 730 shares on 5/01/2018; (c) 1,956 unvested restricted stock units (RSUs) which vest as follows: 489 on 2/27/2016, 489 on 2/27/2017, 489 on 2/27/2018 and 489 on 2/27/2019. Each RSU represents a contingent right to receive one share of common stock.
(2) 945 stock options have vested as of the reporting date. The remaining 19,652 outstanding stock options will vest as follows: 945 on 5/01/2016, 945 on 5/01/2017, and 17,762 on 5/01/2018.
(3) Stock options will vest as follows: 2,157 on 2/27/2016, 2,158 on 2/27/2017, 2,158 on 2/27/2018 and 2,158 on 2/27/2019.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.